Differential Fungicidal Activities of Amphotericin B and Voriconazole against Aspergillus Species Determined by Microbroth Methodology
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Antifungal agents may differ in their fungicidal activities against Aspergillus spp. In order to compare the fungicidal activities of voriconazole and amphotericin B against 40 isolates of Aspergillus fumigatus, A. flavus, and A. terreus, we developed a new microbroth colorimetric method for assessing fungicidal activities and determining minimal fungicidal concentrations (MFCs). This methodology follows the antifungal susceptibility testing reference method M-38A for MIC determination. After drug removal and addition of fresh medium, growth of viable conidia adhering to the bottoms of the microtitration wells was assessed by a colorimetric assay of metabolic activity after 24 h of incubation. The new method was faster (six times), reproducible (92 to 97%), and in agreement with culture-based MFCs (91 to 100%). Differential fungicidal activities of voriconazole and amphotericin B were found among the three Aspergillus species, with A. fumigatus and A. flavus having the lowest (1 and 2 mg/liter, respectively) and A. terreus the highest (>16 mg/liter) median amphotericin B MFCs; A. flavus had a lower median voriconazole MFC (4 mg/liter) than the other species (>8 mg/liter; P < 0.05). Amphotericin B was fungicidal (MFC/MIC </= 4) against all A. fumigatus and A. flavus isolates but no A. terreus isolates, whereas voriconazole was fungicidal against 82% of A. flavus isolates and fungistatic (MFC/MIC > 4) against 94% of A. fumigatus and 84% of A. terreus isolates. The new methodology revealed a concentration-dependent sigmoid pattern of fungicidal effects, indicating that fungicidal activity is not an all-or-nothing phenomenon and that some degree of fungicidal action can be found even for agents considered fungistatic based on the MFC/MIC ratio.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Consequently, the ratio of MFC to MIC in the presence of 1 μM PIT was 4 (Figure 5A), which aligns with the established definition of fungicidal activity (MFC/MIC ≤ 4) [48,49].”
From Pitavastatin Calcium Confers Fungicidal Properties to Fluconazole by Inhibiting Ubiquinone Biosynthesis and Generating Reactive Oxygen Species (2024) · cites this paper as [49]
In the citing paper
“A main advantage of AMB as an anti-A. fumigatus drug is the absence of resistance emergence, due in part to its cidal activity (617).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [617]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Motulsky, H. J., & Christopoulos, A. (2004) · Cited by 1,972
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,573
Invasive Aspergillosis Disease Spectrum, Treatment Practices, and Outcomes
Patterson, T. F., Kirkpatrick, W. R., White, M., Hiemenz, J. W., WINGARD, J. R., DUPONT, B., RINALDI, M. G., STEVENS, D. A., & Graybill, J. R. (2000) · Medicine · doi:10.1097/00005792-200007000-00006 · Cited by 791 · cited 1×
“Invasive aspergillosis in immunocompromised patients is often associated with poor therapeutic outcome (20).”
BackgroundPfaller, M. A., Sheehan, D. J., & Rex, J. H. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.268-280.2004 · Cited by 352 · cited 8×
“Successful treatment of invasive aspergillosis in immunocompromised patients may require fungicidal therapy, which will ultimately achieve eradication of the organism and clinical cure (21).”
BackgroundMethodInfluentialEspinel-Ingroff, A. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.3.954-958.2001 · Cited by 296 · cited 2×
“flavus by culture-based techniques (3, 5, 6, 11), flow cytometry (22), or time-kill assays (13, 25).”
BackgroundSutton, D. A., Sanche, S. E., Revankar, S. G., Fothergill, A. W., & Rinaldi, M. G. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2343-2345.1999 · Cited by 255 · cited 2×
“terreus are concordant with previous findings (5, 24).”
BackgroundResultWalsh, T. J., Petraitis, V., Petraitiene, R., Field‐Ridley, A., Sutton, D., Ghannoum, M., Sein, T., Schaufele, R., Peter, J., Bacher, J., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/377210 · Cited by 253 · cited 3×
“fumigatus (16) 91 (88, 94) 91 (88, 94) 100 (100, 100) 22 (18, 25) 97 (94, 100) 100 (100, 100) A.”
BackgroundSelf-citationIn-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi
Johnson, E. M., Szekely, A., & Warnock, D. W. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.6.741 · Cited by 215 · cited 3×
“25 to 4 mg/liter, implying that voriconazole is fungicidal against these Aspergillus species (5, 11, 27).”
BackgroundEspinel-Ingroff, A., Fothergill, A., Peter, J., Rinaldi, M. G., & Walsh, T. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.9.3204-3208.2002 · Cited by 203 · cited 4×
“These MICs for Aspergillus isolates are similar to previously published MICs where pure powders of voriconazole and amphotericin B were used (9).”
BackgroundMethodResultInfluentialSelf-citationOrganism-Dependent Fungicidal Activities of Azoles
Manavathu, E. K., Cutright, J. L., & Chandrasekar, P. H. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.3018 · Cited by 190 · cited 4×
“terreus (13) 86 (83, 90) 91 (83, 100) 100 (100, 100) 68 (61, 75) 92 (85, 100) 100 (100, 100)”
BackgroundResultInfluential
Research works printed but not linked: 1
- Motulsky, H. 2003. Prism 4 statistics guide-statistical analyses for laboratory and clinical researchers, p. 122-126. GraphPad Software Inc., San Diego, CA.
Cited by
Aspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Antifungal Drug Development: Challenges, Unmet Clinical Needs, and New Approaches
Roemer, T., & Krysan, D. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019703 · Cited by 593
“Azoles inhibit ergosterol biosynthesis and, in general, are fungistatic; an important exception is that voriconazole is fungicidal toward A. fumigatus (Meletiadis et al. 2007).”
BackgroundMolecular Evolution of Antifungal Drug Resistance
Robbins, N., Caplan, T., & Cowen, L. E. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-030117-020345 · Cited by 441
Houšť, J., Spížek, J., & Havlíček, V. (2020) · Metabolites · doi:10.3390/metabo10030106 · Cited by 254
Qin, Y., Li, P., & Guo, Z. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116002 · Cited by 196
Invasive Mold Infections Following Combat-related Injuries
Warkentien, T., Rodriguez, C., Lloyd, B., Wells, J., Weintrob, A., Dunne, J. R., Ganesan, A., Li, P., Bradley, W., Gaskins, L. J., et al. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis749 · Cited by 190
Verweij, P. E., Zhang, J., Debets, A. J. M., Meis, J. F., van de Veerdonk, F. L., Schoustra, S. E., Zwaan, B. J., & Melchers, W. J. G. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)30138-4 · Cited by 140
Trends in antifungal susceptibility testing using CLSI reference and commercial methods
Cantón, E., Espinel-Ingroff, A., & Pemán, J. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.7.1.107 · Cited by 114
Dhingra, S., & Cramer, R. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00092 · Cited by 115
“It is worth noting that azoles are effective in controlling growth of Aspergillus, but they are mostly fungistatic against the majority of A. fumigatus isolates (Meletiadis et al., 2007).”
BackgroundMussin, J. E., Robles-Botero, V., Pimentel, R. G. C., Rojas, F. D., Angiolella, L., Martín‐Martínez, E. S., & Giusiano, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-94012-y · Cited by 116
Proteomic and Transcriptomic Analysis of Aspergillus fumigatus on Exposure to Amphotericin B
Gautam, P., Shankar, J., Madan, T., Sirdeshmukh, R., Sundaram, C. S., Gade, W. N., Basir, S. F., & Sarma, P. U. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01431-07 · Cited by 108
“fumigatus and Aspergillus flavus isolates but not on Aspergillus terreus isolates (25).”
BackgroundMussin, J. E., Roldán, M. V., Rojas, F. D., Sosa, M. D. L. Á., Pellegri, N., & Giusiano, G. (2019) · AMB Express · doi:10.1186/s13568-019-0857-7 · Cited by 101
Fungal keratitis: Mechanisms of infection and management strategies
Donovan, C. P., Arenas, E., Ayyala, R. S., Margo, C. E., & Espana, E. M. (2021) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2021.08.002 · Cited by 97
Mitochondrial dysfunctions trigger the calcium signaling-dependent fungal multidrug resistance
Li, Y., Zhang, Y., Zhang, C., Wang, H., Wei, X., Chen, P., & Lu, L. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911560116 · Cited by 86
“fumigatus (rather than fungicidal) could promote the selection of resistant strains (20, 21).”
BackgroundAntifungal activity of redox-active benzaldehydes that target cellular antioxidation
Jong Heon, K. I. M., Chan, K. L., Mahoney, N. E., & Campbell, B. C. (2011) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/1476-0711-10-23 · Cited by 88
“If MFCFORMULATION/MICFORMULATION was ≤ 4, the formulation was defined as fungicidal, whereas if MFCFORMULATION/MICFORMULATION was > 4, the formulation was defined as fungistatic [49].”
BackgroundEmerging threat of triazole-resistant Aspergillus fumigatus
Rybak, J. M., Fortwendel, J. R., & Rogers, P. D. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky517 · Cited by 80
Kim, J. H., Cheng, L. W., Chan, K. L., Tam, C. C., Mahoney, N., Friedman, M., Shilman, M. M., & Land, K. M. (2020) · Antibiotics · doi:10.3390/antibiotics9110812 · Cited by 71
“The standard dilution methods developed by the CLSI and EUCAST quantitatively determine (1) minimum inhibitory concentrations (MICs) and minimum fungicidal concentrations (MFC) of drugs/compounds via the microdilution assay settings, as well as whether the antifungal efficacy of drugs/compounds is fungicidal or fungis…”
MethodCombat-Related Invasive Fungal Wound Infections
Tribble, D. R., & Rodríguez, C. J. (2014) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0205-y · Cited by 69
Balajee, S. A. (2009) · Medical Mycology · doi:10.1080/13693780802562092 · Cited by 67
Pearce, J. W., Giuliano, E. A., & Moore, C. P. (2009) · Veterinary Ophthalmology · doi:10.1111/j.1463-5224.2009.00721.x · Cited by 68
“Voriconazole has evidence of broader spectrum of activity than other triazole antifungals and appears to have concentration-dependent sigmoid pattern of fungicidal effects against some Aspergillus spp.(32) A recent publication showed it effectively penetrated the cornea in clinically normal horse eyes and achieved det…”
BackgroundPotential Strategies to Control the Risk of Antifungal Resistance in Humans: A Comprehensive Review
Rabaan, A. A., Sulaiman, T., Al-Ahmed, S. H., Buhaliqah, Z. A., Buhaliqah, A. A., AlYuosof, B., Alfaresi, M. S., Fares, M. A. A., Alwarthan, S. M., Alkathlan, M. S., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12030608 · Cited by 66
Discrepancy between histology and culture in filamentous fungal infections
Lee, S., Yun, N. R., Kim, K., Jeon, J. H., Kim, E.-C., Chung, D. H., Park, W. B., & Oh, M. (2010) · Medical Mycology · doi:10.3109/13693780903512835 · Cited by 57
Henneberg, S., Hasenberg, A., Maurer, A., Neumann, F., Bornemann, L., González-Menéndez, I., Kraus, A., Hasenberg, M., Thornton, C. R., Pichler, B. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21965-z · Cited by 54
Gandra, R. M., McCarron, P., Viganor, L., Fernandes, M. F., Kavanagh, K. A., McCann, M., Branquinha, M. H., dos Santos, A. L. S., Howe, O. L., & Devereux, M. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00470 · Cited by 52
Song, J., Zhou, J., Zhang, L., & Li, R. (2020) · Microorganisms · doi:10.3390/microorganisms8101574 · Cited by 51
“The fungistatic nature of the azoles coupled with their extensive use has resulted in azole resistance in populations of various pathogenic fungi [4,6,10,11].”
BackgroundPowers‐Fletcher, M. V., Kendall, B. A., Griffin, A. T., & Hanson, K. E. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0002-2015 · Cited by 59
Antibacterial activity evaluation and mode of action study of novel thiazole-quinolinium derivatives
Li, Y., Sun, N., Ser, H., Long, W. S., Li, Y., Chen, C., Zheng, B., Huang, X., Liu, Z., & Lu, Y. (2020) · RSC Advances · doi:10.1039/d0ra00691b · Cited by 47
Meletiadis, J., Al‐Saigh, R., Velegraki, A., Walsh, T. J., Roilides, E., & Zerva, L. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00662-11 · Cited by 46
Self-citationElefanti, A., Mouton, J. W., Verweij, P. E., Tsakris, A., Zerva, L., & Meletiadis, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00597-13 · Cited by 43
“with 10% of growth (FC90) with the XTT methodology (43).”
BackgroundMethodInfluentialSelf-citationSusceptibility Test Methods: Yeasts and Filamentous Fungi
Johnson, E. M., & Arendrup, M. C. (2015) · ASM Press eBooks · doi:10.1128/9781555817381.ch131 · Cited by 46
Feng, Y., Lu, H., Whiteway, M., & Jiang, Y. (2023) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2023.10.019 · Cited by 40
Treatment of Aspergillus terreus infections: A clinical problem not yet resolved
Pastor, F. J., & Guarro, J. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.07.002 · Cited by 40
“This could explain the reported in vitro ungistatic effect of AmB against this fungus [40] and its poor effiacy against A.”
BackgroundInfluentialSphingolipids: Regulators of azole drug resistance and fungal pathogenicity
Song, J., Xiao, L., & Li, R. (2020) · Molecular Microbiology · doi:10.1111/mmi.14586 · Cited by 39
“Since these azoles have mainly fungistatic activity against pathogenic fungi (Meletiadis et al., 2007), their extensive use has resulted in drug resistance in populations of various pathogenic fungi (Chowdhary and Meis, 2018; Revie et al., 2018; Song et al., 2018); thus, there is a need for more…”
BackgroundTreatment of Suspected Invasive Fungal Infection in War Wounds
Rodríguez, C. J., Tribble, D. R., Malone, D. L., Murray, C. K., Jessie, E., Khan, M. A., Fleming, M. E., Potter, B. K., Gordon, W. T., & Shackelford, S. A. (2018) · Military Medicine · doi:10.1093/milmed/usy079 · Cited by 38
Wiederhold, N. P., & Lewis, R. E. (2008) · Medical Mycology · doi:10.1080/13693780802510224 · Cited by 39
In vitro Susceptibility Testing in Aspergillus Species: An Update
Lass-Flörl, C. (2010) · Future Microbiology · doi:10.2217/fmb.10.34 · Cited by 36
Ahamefule, C. S., Qin, Q., Odiba, A. S., Li, S., Moneke, A. N., Ogbonna, J. C., Jin, C., Wang, B., & Fang, W. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00320 · Cited by 38
Aspergillus terreus and the Interplay with Amphotericin B: from Resistance to Tolerance?
Vahedi‐Shahandashti, R., Dietl, A., Binder, U., Nagl, M., Würzner, R., & Lass‐Flörl, C. (2022) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02274-21 · Cited by 34
Colley, T., Sehra, G., Chowdhary, A., Alanio, A., Kelly, S. L., Kizawa, Y., Armstrong-James, D. P. H., Fisher, M. C., Warrilow, A. G. S., Parker, J. E., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01941-17 · Cited by 32
“After the MIC for each compound was recorded, fungicidal activity was determined as previously described (35).”
MethodMovahed, E., Tan, G. M. Y., Munusamy, K., Yeow, T. C., Tay, S. T., Wong, W. F., & Looi, C. Y. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00360 · Cited by 35
“Triclosan was considered fungicidal when the MFC/MIC ratio is ≤4 and fungistatic when the MFC/MIC ratio is ≥4 (Pfaller et al., 2004; Meletiadis et al., 2007).”
BackgroundMethodVaezi, A., Fakhim, H., Arastehfar, A. A., Shokohi, T., Hedayati, M. T., Khodavaisy, S., Rezaei‐Matehkolaei, A., Badiee, P., Hagen, F., Lass‐Flörl, C., et al. (2017) · Mycoses · doi:10.1111/myc.12716 · Cited by 30
Efficacy of Voriconazole against Aspergillus fumigatus Infection Depends on Host Immune Function
Rosowski, E. E., He, J., Huisken, J., Keller, N. P., & Huttenlocher, A. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00917-19 · Cited by 31
“fumigatus germination and killing hyphae postgermination (19, 20), but we find that only the latter occurs in infected, voriconazole-treated larval zebrafish.”
BackgroundMoreno, Á., Mah, J., Budvytiene, I., Ho, D. Y., Schwenk, H. T., & Banaei, N. (2024) · Journal of Clinical Microbiology · doi:10.1128/jcm.00394-24 · Cited by 29
“…whereas voriconazole, the first-line treatment for invasive aspergillosis infections, is generally regarded as fungicidal for filamentous molds (30) but may have fungistatic or fungicidal activity depending on the minimal fungicidal concentration over minimal inhibitory concentration ratio (31).”
BackgroundElefanti, A., Mouton, J. W., Krompa, K., Al-Saigh, R., Verweij, P. E., Zerva, L., & Meletiadis, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01573-12 · Cited by 27
“terreus and a fungistatic action (FC/IC 4) of voriconazole against of all three species, although the FC10s were smaller than the corresponding ones of amphotericin B, in agreement with previous studies (8, 36).”
BackgroundMethodResultInfluentialSelf-citationUpdates in antifungal susceptibility testing of filamentous fungi
Espinel‐Ingroff, A., Canton, E., & Pemán, J. (2009) · Current Fungal Infection Reports · doi:10.1007/s12281-009-0017-7 · Cited by 29
Targeting DNA Topoisomerase II in Antifungal Chemotherapy
Kondaka, K., & Gabriel, I. (2022) · Molecules · doi:10.3390/molecules27227768 · Cited by 25
“albicans [4,5] Alternative antifungal targets are needed so as to expand the range of therapeutic options, especially the enzymes that are important for the biosynthesis of proteins, amino acids or DNA processing [6–8].”
BackgroundKhoury, M., Beyrouthy, M. E., Ouaïni, N., Éparvier, V., & Stien, D. (2019) · Fitoterapia · doi:10.1016/j.fitote.2019.01.001 · Cited by 25
Jong Heon, K. I. M., Haff, R. P., Faria, N., Martins, M. D. L., Chan, K. L., & Campbell, B. (2013) · Molecules · doi:10.3390/molecules18088873 · Cited by 24
“, Mean MFCcombined for 2,3-DHBA or PCS/ Mean MICcombined for 2,3-DHBA or PCS was > 4 [See [35] for reference]), in most Cryptococcus strains tested.”
BackgroundBarceló, S., Peralta, M. A., Calise, M., Finck, S., Ortega, G., Diez, R. A., Cabrera, J. L., & Pérez, C. (2017) · Phytomedicine · doi:10.1016/j.phymed.2017.05.001 · Cited by 21
The antimicrobial and immunomodulatory effects of Ionophores for the treatment of human infection
Li, G., Oliveira, D. M. P. D., & Walker, M. J. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2021.111661 · Cited by 22
Barchiesi, F., Spreghini, E., Sanguinetti, M., Giannini, D., Manso, E., Castelli, P., & Girmenia, C. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt232 · Cited by 19
Perkhofer, S., Trappl, K., Striessnig, B., Nußbaumer, W., & Lass‐Flörl, C. (2010) · Medical Mycology · doi:10.3109/13693786.2010.510150 · Cited by 17
Zhen, C., Wang, L., Feng, Y., Whiteway, M., Hang, S., Yu, J., Lu, H., & Jiang, Y. (2024) · Advanced Science · doi:10.1002/advs.202406473 · Cited by 16
Guanylation Significantly Enhances the Antifungal Activity of Poly(α-lysine)
Liu, H., Han, M., Liu, X., & Ji, S. (2022) · ACS Applied Polymer Materials · doi:10.1021/acsapm.2c01205 · Cited by 15
Al‐Saigh, R., Siopi, M., Siafakas, N., Velegraki, A., Zerva, L., & Meletiadis, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02484-12 · Cited by 15
“Lack of in vivo efficacy, however, was not associated with significantly increased MIC values (3, 25, 26), which remained similar for all three species examined in the present study (13, 27).”
BackgroundMethodSelf-citationLi, W., Feng, Y., Feng, Z., Wang, L., Whiteway, M., Lu, H., & Jiang, Y. (2024) · Antioxidants · doi:10.3390/antiox13060667 · Cited by 14
“Consequently, the ratio of MFC to MIC in the presence of 1 µ M PIT was 4 (Figure 5A), which aligns with the established definition of fungicidal activity (MFC/MIC ≤ 4) [48,49].”
MethodWołuń-Cholewa, M., Szymanowski, K., Nowak‐Markwitz, E., & Warchol, W. J. (2011) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2010.12.003 · Cited by 14
Arseniu, A. M., Marc, G., Ionuţ, I. A., Vodnar, D. C., Vlase, L., Gligor, F. G., Pricopie, A., Pîrnău, A., Tiperciuc, B., & Oniga, O. (2019) · Molecules · doi:10.3390/molecules24010184 · Cited by 13
“All our tested compounds have a MFC/MIC ratio equal to 2, indicating that these compounds behave as fungicidal agents [21].”
BackgroundJha, A., & Kumar, A. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2018-0479 · Cited by 12
Fernández, M. S., Rojas, F. D., Cattana, M. E., Sosa, M. D. L. Á., Iovannitti, C., Lass‐Flörl, C., & Giusiano, G. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00045-15 · Cited by 11
“terreus with MICs higher than the ECV for voriconazole and itraconazole (9, 17, 18, 20, 31).”
BackgroundMussin, J. E., & Giusiano, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-51358-0_17 · Cited by 16
Barreales, E. G., Rumbero, Á., Payero, T. D., de Pedro, A., Jambrina, E., & Aparicio, J. F. (2020) · Antibiotics · doi:10.3390/antibiotics9070413 · Cited by 9
“The MFC/MIC ratio was calculated to determine whether the substances exhibited fungistatic (MFC/MIC > 4) or fungicidal activity (MFC/MIC < 4) [36].”
MethodNegro, M. F., Bustos, P. S., Bellezze, L., Ortega, M. G., Echeverría, J., Silva, M. F., & Peralta, M. A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1643472 · Cited by 8
Therapeutic Approaches for Combating Aspergillus Associated Infection
Chhillar, A. K., Punia, A., Choudhary, P., Sharma, N., Dahiya, S., & Gulia, P. (2022) · Current Drug Targets · doi:10.2174/1389450123666220623164548 · Cited by 10
Studies on Function of P-Glycoprotein in Photodynamic Therapy of Endometriosis
Wołuń-Cholewa, M., Szymanowski, K., Andrusiewicz, M., & Warchol, W. J. (2010) · Photomedicine and Laser Surgery · doi:10.1089/pho.2009.2657 · Cited by 8
Mohamadnia, A., Salehi, Z., Namvar, Z., Tabarsi, P., Pourabdollah-Toutkaboni, M., Rezaie, S., Marjani, M., Moniri, A., Abtahian, Z., Mahdaviani, S. A., et al. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101004 · Cited by 8
Fattahi, A., Zaini, F., Kordbacheh, P., Hashemi, S. J., Mahmoudi, M., & Safara, M. (2012) · PubMed · Cited by 8
Susceptibility Test Methods: Yeasts and Filamentous Fungi
Johnson, E. M., Espinel-Ingroff, A. V., & Pfaller, M. A. (2011) · Wiley eBooks · doi:10.1128/9781555816728.ch128 · Cited by 10
Guinn, L., Lo, E., & Balázsi, G. (2022) · Communications Biology · doi:10.1038/s42003-022-03228-9 · Cited by 7
Albarracin, L. T., Delgado, W. A., Suárez, L. E. C., & Murillo, M. C. Á. (2017) · Natural Product Research · doi:10.1080/14786419.2017.1408090 · Cited by 7
“The determination of MFC was performed for all samples to which MIC and IC50 were determined (Meletiadis et al. 2007).”
MethodShen, M., Li, P., Wu, Y.-J., Lin, C., Chai, E., Chang, T., & Chen, C. (2019) · Medical Mycology · doi:10.1093/mmy/myz071 · Cited by 6
Griseococcin (1) from Bovistella radicata (Mont.) Pat and antifungal activity
Ye, Y., Zeng, Q., & Zeng, Q. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01961-x · Cited by 6
Le, T. T., Tien, D. N., Nguyen-Van, M.-T., Huynh, T. N. B., Dinh, T., Huynh, C. D. M., Nguyen, P. D. T., Ho, T. N. V., Tran-Van, H., & Hoang, V. (2025) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2025.102570 · Cited by 6
Antifungal efficacy of octylgallate and 4-isopropyl-3-methylphenol for control of Aspergillus
Jong Heon, K. I. M., Hart‐Cooper, W., Chan, K. L., Cheng, L. W., Orts, W. J., & Johnson, K. (2016) · Microbiology Discovery · doi:10.7243/2052-6180-4-2 · Cited by 5
Tan, J., Yang, J., Aobulikasimu, N., Zhang, C., Cao, B., Lv, H., Jiang, M., Han, L., & Huang, X. (2023) · Pest Management Science · doi:10.1002/ps.7696 · Cited by 5
Lindenmann, J., Fink‐Neuboeck, N., Leitner, E., Grisold, A. J., Kohek, P. H., & Smolle-Juettner, F. M. (2016) · Microbiology Discovery · doi:10.7243/2052-6180-4-3 · Cited by 5
Bioactive molecules from microalgae and constraints in commercialization
Singh, U., Laxmi, L., Singh, A. K., & Asthana, R. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820655-3.00007-0 · Cited by 7
Mo, P. M., Picard, J., & Gummow, B. (2023) · Veterinary Research Communications · doi:10.1007/s11259-023-10119-9 · Cited by 4
Ramli, A. H., Jayathilaka, E. H. T. T., Dias, M. K. H. M., Malek, E. A., Jain, N., An, J., Churchill, D. G., Rukayadi, Y., Swain, P., Kim, C., et al. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.106797 · Cited by 4
Santos, F. D. C. V., Martins, G. R., Luiz, S. R. D. S., Oliveira, I. D. A., da Silva, L. P., da Silva, A. J. R., Pereira, M. D., Lopes, R. C., Alviano, C. S., & Alviano, D. S. (2025) · Antioxidants · doi:10.3390/antiox14020181 · Cited by 4
“From the MIC, the microbicidal effect was considered when the ratio (MBC or MFC/MIC) is ≤ 4 and microbiostatic when (MBC or MFC/MIC) is >4 [28–30].”
Kiraz, N., Öz, Y., & Dağ, İ. (2011) · Medical Mycology · doi:10.3109/13693786.2011.555847 · Cited by 4
Nishi, I., Sunada, A., Toyokawa, M., Asari, S., & Iwatani, Y. (2011) · Journal of Chemotherapy · doi:10.1179/joc.2011.23.2.102 · Cited by 4
Gunawan, U., Ibrahim, S., Ivansyah, A. L., & Damayanti, S. (2023) · Pharmacia · doi:10.3897/pharmacia.70.e111511 · Cited by 4
Tatara, A. M., Watson, E., Albert, N. D., Kontoyiannis, P. D., Kontoyiannis, D. P., & Mikos, A. G. (2019) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36671 · Cited by 4
Oak, A. S. W., Baddley, J. W., & Elewski, B. E. (2018) · Springer eBooks · doi:10.1007/978-3-319-66884-0_40 · Cited by 6
Talas, F., Stapley, J., & McDonald, B. A. (2026) · Pest Management Science · doi:10.1002/ps.70483 · Cited by 3
Lewis, R. E. (2009) · Springer eBooks · doi:10.1007/978-90-481-2408-4_17 · Cited by 5
Human-like Biofilm Models to Study the Activity of Antifungals Against Aspergillus fumigatus
Furnica, D.-T., Falkenstein, J., Dittmer, S., Steinmann, J., Rath, P., & Kirchhoff, L. (2025) · Microorganisms · doi:10.3390/microorganisms13092040 · Cited by 2
“The fungistatic and fungicidal effects of the three compounds were in line with the ones described in the current literature [10,23–25].”
Romero, O., Galarneau, M., Pladwig, S., Liu, B., Cox, S. L., & Geddes‐McAlister, J. (2025) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2025.104016 · Cited by 2
Powers‐Fletcher, M. V., Kendall, B. A., Griffin, A. T., & Hanson, K. E. (2016) · ASM Press eBooks · doi:10.1128/9781555819040.ch14 · Cited by 2
Gonzales-Huerta, L. E., Williams, T. J., Aljohani, R., Robertson, B. D., Evans, C. A., & Armstrong-James, D. P. H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.15.615211 · Cited by 2
Gadali, K. E., Rafya, M., Mansouri, A. E., Mehdi, A., Andreï, G., Snoeck, R., Benkhalti, F., Sanghvi, Y. S., Taourirte, M., & Lazrek, H. B. (2026) · Molecular Diversity · doi:10.1007/s11030-026-11505-6 · Cited by 1
“Typically, a compound is classified as fungicidal when its MIC/MFC ratio is ≤ 4, while a ratio greater than 4 suggests fungistatic activ - ity [27].”
Kumar, M., Kajal, K., Taranum, N., Khyati, Balan, B., Kumar, P., & Dhaulaniya, A. S. (2024) · Springer eBooks · doi:10.1007/978-981-97-5165-5_22 · Cited by 2
Susceptibility Test Methods: Yeasts and Filamentous Fungi
Johnson, E. M., & Arendrup, M. C. (2023) · Wiley eBooks · doi:10.1002/9781683674849.mcm0135 · Cited by 3
Susceptibility Test Methods: Yeasts and Filamentous Fungi
Johnson, E. M., & Arendrup, M. C. (2023) · Wiley eBooks · doi:10.1002/9781683670438.mcm0135 · Cited by 1
Challenging the Paradigm of Clinical Triazole Resistance in Aspergillus fumigatus
Rybak, J. M. (2019) · doi:10.21007/etd.cghs.2019.0487 · Cited by 1
Sasse, C. (2008) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-291
Maran, K., Adams, R., Khan, A., & Chen, S. F. (2025) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piaf103
Additional file 1 of Griseococcin (1) from Bovistella radicata (Mont.) Pat and antifungal activity
Ye, Y., Zeng, Q., & Zeng, Q. (2020) · Figshare · doi:10.6084/m9.figshare.12940618
Costa, A. A. A. (2017) · Americanae (AECID Library)
Metadata
- Authors
- Meletiadis, J., Antachopoulos, C., Stergiopoulou, T., Pournaras, S., Roilides, E., & Walsh, T. J.
- Affiliations
- National Cancer Institute (US)
- University of Thessaly (GR)
- Aristotle University of Thessaloniki (GR)
- ORCID
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2007-09
- Volume
- 51
- Issue
- 9
- Pages
- 3329-3337
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2043246
- OpenAlex
- W2138700722
- Cited by
- 100
- References
- 26
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 7 · 2022: 5 · 2021: 4 · 2020: 14 · 2019: 10 · 2018: 4 · 2017: 5 · 2016: 6 · 2015: 2 · 2014: 3 · 2013: 5 · 2012: 2
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ORBi (University of Liège) (submittedVersion, other-oa)
- University of Thessaly Institutional Repository (University of Thessaly) (submittedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Keywords
- amphotericin B, voriconazole, Aspergillus fumigatus, Aspergillus flavus, Aspergillus terreus, fungicidal activity, minimum fungicidal concentration, antifungal susceptibility testing
- MeSH terms
- Amphotericin B, Antifungal Agents, Aspergillus, Colorimetry, Culture Media, Microbial Sensitivity Tests, Pyrimidines, Quality Control, Regression Analysis, Species Specificity, Spores, Fungal, Tetrazolium Salts, Triazoles, Colony Count, Microbial, Reproducibility of Results, Vitamin K 3, Voriconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.